Tisdag 3 Juni | 04:16:56 Europe / Stockholm

Kalender

Est. tid*
2025-08-27 12:50 Kvartalsrapport 2025-Q2
2025-06-26 N/A X-dag ordinarie utdelning ABTEC 0.00 NOK
2025-06-25 N/A Årsstämma
2025-05-02 - Bokslutskommuniké 2024
2025-04-09 - Extra Bolagsstämma 2025
2024-11-13 - Extra Bolagsstämma 2024
2024-08-23 - Kvartalsrapport 2024-Q2
2024-07-01 - X-dag ordinarie utdelning ABTEC 0.00 NOK
2024-06-28 - Årsstämma
2024-06-14 - Bokslutskommuniké 2023
2023-08-24 - Kvartalsrapport 2023-Q2
2023-06-12 - X-dag ordinarie utdelning ABTEC 0.00 NOK
2023-06-09 - Årsstämma
2023-04-28 - Bokslutskommuniké 2022
2022-08-24 - Kvartalsrapport 2022-Q2
2022-06-10 - X-dag ordinarie utdelning ABTEC 0.00 NOK
2022-06-09 - Årsstämma
2022-04-29 - Bokslutskommuniké 2021
2021-08-25 - Kvartalsrapport 2021-Q2
2021-06-10 - X-dag ordinarie utdelning ABTEC 0.00 NOK
2021-06-09 - Årsstämma
2021-04-30 - Bokslutskommuniké 2020
2020-09-11 - Extra Bolagsstämma 2020
2020-08-26 - Kvartalsrapport 2020-Q2
2020-06-11 - X-dag ordinarie utdelning ABTEC 0.00 NOK
2020-06-10 - Årsstämma
2020-04-15 - Bokslutskommuniké 2019
2019-08-28 - Kvartalsrapport 2019-Q2
2019-06-06 - X-dag ordinarie utdelning ABTEC 0.00 NOK
2019-06-05 - Årsstämma
2019-04-24 - Bokslutskommuniké 2018
2019-01-07 - Extra Bolagsstämma 2019
2018-08-22 - Kvartalsrapport 2018-Q2
2018-05-30 - Årsstämma
2018-02-21 - Bokslutskommuniké 2017
2017-08-16 - Kvartalsrapport 2017-Q2
2017-06-08 - X-dag ordinarie utdelning ABTEC 1.00 NOK
2017-06-07 - Årsstämma
2017-02-15 - Bokslutskommuniké 2016
2016-11-18 - X-dag bonusutdelning ABTEC 1
2016-11-17 - Extra Bolagsstämma 2016
2016-11-17 - 15-10 2016-Q3
2016-08-17 - Kvartalsrapport 2016-Q2
2016-06-09 - X-dag ordinarie utdelning ABTEC 1.50 NOK
2016-06-08 - Årsstämma
2016-02-10 - Bokslutskommuniké 2015
2015-11-18 - Kvartalsrapport 2015-Q3
2015-08-19 - Kvartalsrapport 2015-Q2
2015-06-04 - X-dag ordinarie utdelning ABTEC 1.00 NOK
2015-06-03 - Årsstämma
2015-05-13 - Kvartalsrapport 2015-Q1
2015-02-11 - Bokslutskommuniké 2014
2014-11-26 - Kvartalsrapport 2014-Q3
2014-08-20 - Kvartalsrapport 2014-Q2
2014-06-11 - Årsstämma
2014-05-21 - Kvartalsrapport 2014-Q1
2014-02-12 - Bokslutskommuniké 2013
2013-11-27 - Kvartalsrapport 2013-Q3
2013-08-21 - Kvartalsrapport 2013-Q2
2013-06-13 - Kapitalmarknadsdag 2013
2013-06-12 - X-dag ordinarie utdelning
2013-06-11 - Årsstämma
2013-05-22 - Kvartalsrapport 2013-Q1
2013-02-13 - Bokslutskommuniké 2012
2012-11-27 - Kvartalsrapport 2012-Q3
2012-08-28 - Kvartalsrapport 2012-Q2
2012-06-14 - Årsstämma
2012-05-23 - Kvartalsrapport 2012-Q1
2012-02-17 - Bokslutskommuniké 2011
2011-11-30 - Kvartalsrapport 2011-Q3
2011-08-29 - Kvartalsrapport 2011-Q2
2011-06-17 - X-dag ordinarie utdelning
2011-06-16 - Årsstämma
2011-05-30 - Kvartalsrapport 2011-Q1
2011-02-18 - Bokslutskommuniké 2010

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriBioteknik
Aqua Bio Technology är ett norskt bolag verksamma inom kosmetikabranschen. Bolaget utvecklar, tillverkar och kommersialiserar ingredienser som används inom ett flertal kosmetiska produkter världen över. Störst verksamhet återfinns inom lösningar för hudvårdsprodukter. Merparten av bolagets produkter säljs på en global marknad via diverse distributörer. Bolaget grundades 2004 och har sitt huvudkontor i Lysaker.
2025-05-01 08:00:05
1.5.2025 08:00:00 CEST | Aqua Bio Technology ASA | Annual financial and audit
reports

Aqua Bio Technology ASA ("ABTEC" and, together with its subsidiaries, "the
Group") today publishes the Group's annual report for the financial year 2024.

Key Financial Highlights (Group):

* Operating revenues: NOK 107.2 million (2023: NOK 18.7 million)
* EBITDA: NOK -313.9 million (2023: NOK -12.1 million)
* Operating result (EBIT): NOK -325.7 million (2023: NOK -15.8 million)
* Net result: NOK -337.4 million (2023: NOK -21.0 million)
* Cash flow from operations: NOK -46.9 million (2023: NOK -19.3 million)

The result for the year was significantly impacted by impairments in the Group's
balance sheet. An accounting loss of NOK 44.7 million was recognized due to the
bankruptcy of a subsidiary, in addition to impairments of other subsidiaries
amounting to NOK 163.7 million.

Financial Position as of 31.12.2024:

* Total assets: NOK 249.7 million (2023: NOK 237.7 million)
* Cash balance: NOK 17.2 million (2023: NOK 4.8 million)
* Equity: NOK -81.7 million (2023: positive)
* Equity ratio: -32.7% (2023: positive)
* Long-term debt and liabilities: NOK 331.4 million

The increase in the Group's assets is primarily due to business acquisitions
during the year. The negative equity and weakened key figures reflect the
significant challenges the Group faced in 2024.

Matters Related to Transactions and Accounting Uncertainty:

As previously reported, the Board has become aware of a significant volume of
related party transactions in three subsidiaries and initiated an external
investigation. At the time of issuing the annual report, sufficient
documentation or business rationale for these transactions could not be
obtained. The auditor has informed that, on this basis, they will not issue an
audit opinion for the consolidated financial statements, although the parent
company's financial statements will receive an opinion. Due to the considerable
uncertainty related to the aforementioned matters, the Board reserves judgment
regarding the accuracy of the Group's consolidated figures concerning these
subsidiaries and transactions and cannot currently reach a conclusion.

Parent Company Key Figures:

* Assets: NOK 149.7 million (2023: NOK 99.6 million)
* Equity: NOK 6.1 million (2023: NOK 62.7 million)
* Debt: NOK 143.5 million (2023: NOK 36.9 million)
* Net result: NOK -233,164,479

The Board will propose to the General Meeting that no dividend be paid for the
financial year 2024, and that the year's result be transferred to uncovered
loss.

Accounting Principles:

The consolidated financial statements are prepared in accordance with
International Financial Reporting Standards (IFRS), while the parent company's
financial statements are prepared under the Norwegian Accounting Act and
generally accepted accounting principles (NGAAP).

Note on Auditor's Report and ESEF Reporting:

The auditor's report is not finalized at the time of publication of today's
figures, as the establishment of ESEF reporting (European Single Electronic
Format) has not been completed by the deadline. It is expected that the ESEF
reporting will be finalized in the coming days, and the auditor's report will,
in accordance with regulations, be issued when the reporting is complete.





DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Fredrik Henriksen, CEO, Aqua Bio Technology ASA, +47 90 02 00 78,
fredrik.henriksen@aquabiotech.no
* Geir Udnæs, CFO, Aqua Bio Technology ASA, +47 91 36 18 93,
geir.udnaes@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology ASA (ABTEC) is a distribution group in skincare and nonfood.
The group has distribution towards B2C, B2B, B2B2, and freight, customs, and
logistics services. The group also develops sustainable biotechnology for use in
skincare products. Aqua Bio Technology is listed on the Euronext Expand market
of the Oslo Stock Exchange.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/18512998/6035/Download%20announce
ment%20as%20PDF.pdf

Annual report ABTEC 2024 signed.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/18512998/6034/Annual%20report%20A
BTEC%202024%20signed.pdf